Cathie Wood’s ARK buys Roblox, sells Robinhood in latest trades

Published 07/02/2025, 02:04
© Reuters

Cathie Wood’s ARK ETFs have once again made significant moves in the stock market, as evidenced by the daily trade report for Thursday, February 6th, 2025. The investment management firm, known for its focus on innovative and disruptive technologies, has continued to adjust its portfolio with a mix of buys and sells that could signal its strategic direction.

In the largest dollar-value trade of the day, ARK purchased a total of 368,676 shares of Roblox Corp (NYSE:RBLX), spreading the acquisition across three of its funds: ARKK, ARKW, and ARKF. The total investment amounted to $27,823,978, making it a substantial bet on the online gaming platform’s future growth.

On the selling side, ARK divested a sizable number of shares from Robinhood Markets Inc (NASDAQ:HOOD), totaling 339,757 across ARKK, ARKW, and ARKF, with a total value of $18,414,829. This move might indicate a shift in confidence regarding the financial services company, which has been a staple in ARK’s portfolio.

Another notable transaction involved the sale of 91,785 shares of Palantir Technologies Inc (NYSE:NASDAQ:PLTR) solely through its ARKK ETF, worth $9,303,327. Palantir, a company specializing in big data analytics, has seen fluctuating interest from ARK over the past week, suggesting a possible reassessment of its position within ARK’s investment strategy.

In terms of buys, ARK showed interest in the semiconductor space, acquiring 54,371 shares of Qualcomm Inc (NASDAQ:QCOM) between its ARKQ and ARKW funds, totaling $9,561,684. This investment aligns with the growing demand for advanced chip technology across various industries.

Other purchases included 56,940 shares of PagerDuty Inc (NYSE:PD) valued at $1,092,678, 95,850 shares of Symbotic Inc (NASDAQ:SYM) worth $2,963,682, 62,435 shares of Twist Bioscience Corp (NASDAQ:TWST) at $3,350,262, and 250,241 shares of 10X Genomics Inc (NASDAQ:TXG) with a total value of $3,678,542. These acquisitions highlight ARK’s continued interest in the health-tech and automation sectors.

On the smaller end of the scale, ARK’s trades included the sale of 306,281 shares of Accolade Inc (NASDAQ:ACCD) through its ARKG ETF, totaling $2,113,338, and a minor sell of 100 shares of Adyen NV (AS:ADYEN) (OTCMKTS:ADYEY) via its ARKW ETF, amounting to $1,667. The firm also bought 153 shares of Amazon.com Inc (NASDAQ:AMZN) through its ARKF ETF for $36,134, signaling a modest increase in its stake in the e-commerce giant.

Looking at the past week’s trades, a pattern emerges with consistent selling of ACCOLADE INC (ACCD), PALANTIR TECHNOLOGIES INC (PLTR), and ADYEN NV (ADYEY), suggesting a strategic move away from these positions. Conversely, ARK has been accumulating shares of TWIST BIOSCIENCE CORP (TWST) and 10X GENOMICS INC (TXG), indicating a growing interest in these companies.

Investors and market watchers will undoubtedly keep a close eye on ARK’s trades, as Cathie Wood’s investment decisions have been known to influence market trends, particularly within the technology and innovation sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.